The side effects of ACEIs and ARBs may be resulting in less frequent use in a population that could benefit from these medications. A new study found that continuous ACEI/ARB use prior to dialysis ...

inpatient treatment with ACEI [ACE inhibitor]/ARB [angiotensin receptor blocker] was associated with lower risk of all-cause mortality, compared with ACEI/ARB nonusers, during 28 days of follow-up.

Multivariate logistic regression was used to identify factors associated with ACEi or ARB initiation. RESULTS: Among 15,400 eligible patients without prior ACEi or ARB treatment, only 17% ...

A long-running dispute as to the supremacy of angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) in the treatment of cardiovascular disease should be put to bed ...

Patients receiving an angiotensin-converting enzyme (ACE) inhibitor or an angiotensin II receptor blocker (ARB) who had mild chronic kidney disease (CKD) that became advanced had better 5-year ...

The combination is best used only when necessary and at the lowest effective doses of spironolactone and an ACEI/ARB. In a recent meta-analysis, Lorenzo Villa-Zapata, PharmD, PhD, Clinical ...

ACEI and ARB is presumed to be unsafe for use during the COVID-19 pandemic as these could increase the risk of infection. However, leading global health authorities recommend their use. ACEI and ...

Study: Comparing clinical outcomes of ARB and ACEi in patients hospitalized for acute COVID-19. Image Credit: CKA/Shutterstock.com As of April 2022, severe acute respiratory syndrome coronavirus 2 ...

The analysis looks at the mortality rate for those who continued or started ACEi/ARB treatment and those who discontinued or did not initiate the treatment. Withdrawal of angiotensin-converting ...

Patients with heart failure who start taking sacubitril/valsartan (Entresto; Novartis) do not appear to have a greater risk of angioedema than do those who opt for an ACE inhibitor or ARB instead, an ...

Lowering your blood pressure with medications including ACE inhibitors and ARBs may reduce the risks of AFib. Most people who take ACE inhibitors and ARBs are likely to be on these medications for ...

More information: Smruti K. Nair et al, Clinical studies in Myxomatous Mitral Valve Disease dogs: most prescribed ACEI inhibits ACE2 enzyme activity and ARB increases AngII pool in plasma ...